The Pharmaceutical Society of Australia (PSA) is urging all states and territories to introduce free, needle-free influenza vaccines for children aged 2 to under 5, following recent moves by Queensland and New South Wales (NSW).
PSA National President, Associate Professor Fei Sim FPS, says vaccination coverage among young children remains unacceptably low, with uptake in some jurisdictions below 20%.
“We congratulate the Queensland and New South Wales governments for showing leadership and putting children’s health first,” says Associate Professor Sim.
“Too many children are missing out on flu vaccination, and parents consistently tell us that the fear of needles is a barrier.
“A nasal spray option changes that, and we know from overseas experience that uptake of vaccines improves dramatically.
“Pharmacists are ready to deliver these vaccines in every community — but we need every government to come on board.”
Influenza is one of the most common reasons children present to emergency departments during winter, placing significant strain on hospitals and families.
Associate Professor Sim highlights South Australia’s example of removing legislative barriers to pharmacy vaccination.
“It’s time for all jurisdictions to modernise legislation so every child, no matter their postcode, can access free, convenient, and needle-free protection,” she says.
PSA Vaccination Ambassador Anna Theophilos MPS says needle-free vaccines would make a real difference for families.
“Parents often worry about the stress of needles for young children, especially those with sensory needs.
“A nasal spray takes away that anxiety and makes it easier for families to protect their kids,” she says.
Associate Professor Sim points out that while state programs are essential now, long-term equity requires national leadership and harmonisation across jurisdictions.
“We note that FluMist is currently being considered by the Pharmaceutical Benefits Advisory Committee for the National Immunisation Program.
“Federal funding will be critical for national consistency — but until then, states and territories must step up to protect children against this vaccine-preventable disease,” she says.
The PSA will launch a dedicated webinar, quick reference guid, and learning module in October 2025 to support pharmacists integrating intranasal influenza vaccination into practice.
